Jasmine Kway - Jul 5, 2023 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Signature
/s/ Jasmine Kway
Stock symbol
VNRX
Transactions as of
Jul 5, 2023
Transactions value $
$0
Form type
4
Date filed
7/7/2023, 04:01 PM
Previous filing
Jan 13, 2023
Next filing
Aug 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VNRX Common Stock Award $0 +22.1K +40.54% $0.00 76.4K Jul 5, 2023 Direct F1
holding VNRX Common Stock 5.4K Jul 5, 2023 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 4, 2022, the reporting person was awarded 49,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 22,050 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 7,350 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in October 2022 and January 2023 respectively, the rights with respect to 8,575 RSUs and 18,375 RSUs subject to the award previously vested and remain subject to time-based vesting.